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Aspergillus fumigatus is the main etiologic agent of invasive aspergillosis (IA). Other
Aspergillus species belonging to the section Fumigati (A. fumigatus complex) may
occasionally be the cause of IA. These strains are often misidentified, as they
cannot be distinguished from A. fumigatus by conventional morphological analysis
and sequencing methods. This lack of recognition may have important consequences
as these A. fumigatus-related species often display some level of intrinsic resistance
to azoles and other antifungal drugs. A. lentulus, A. udagawae, A. viridinutans, and
A. thermomutatus (Neosartorya pseudofischeri) have been associated with refractory
cases of IA. Microbiologists should be able to suspect the presence of these
cryptic species behind a putative A. fumigatus isolate on the basis of some simple
characteristics, such as defect in sporulation and/or unusual antifungal susceptibility
profile. However, definitive species identification requires specific sequencing analyses
of the beta-tubulin or calmodulin genes, which are not available in most laboratories.
Multiplex PCR assays or matrix-assisted laser desorption ionization – time-of-flight mass
spectrometry (MALDI-TOF MS) gave promising results for rapid and accurate distinction
between A. fumigatus and other Aspergillus spp. of the section Fumigati in clinical
practice. Improved diagnostic procedures and antifungal susceptibility testing may be
helpful for the early detection and management of these particular IA cases.
Keywords: Aspergillus section Fumigati, Aspergillus lentulus, Aspergillus udagawae, Aspergillus viridinutans,
Aspergillus felis, Neosartorya fischeri, Neosartorya pseudofischeri, Neosartorya hiratsukae
INTRODUCTION
Aspergillus fumigatus is the most important pathogenic filamentous fungus in humans causing
a spectrum of diseases including allergic bronchopulmonary aspergillosis, chronic pulmonary
aspergillosis and invasive aspergillosis. Among the growing population of patients with depressed
immune defenses, A. fumigatus represents one of the major infectious cause of death. Other
important pathogenic Aspergillus spp. include A. flavus, A. niger, A. terreus, A. versicolor,
A. calidoustus, and A. nidulans (Steinbach et al., 2012). These designations actually represent
sections (or complexes) of closely related species (also referred as cryptic species) that cannot
be clearly distinguished morphologically. While A. fumigatus sensu stricto represents by far
the leading human pathogen, some other species belonging to the A. fumigatus sensu latu
complex (i.e., section Fumigati) have been recognized as occasional causes of invasive aspergillosis
in 3 to 6% of cases (Balajee et al., 2009b; Alastruey-Izquierdo et al., 2013, 2014; Escribano
et al., 2013; Table 1). Their actual prevalence may be underestimated because of their lack
of recognition by conventional diagnostic approaches. Moreover, the diagnosis of invasive
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Portugal 29 1 (3.4%) A. lentulus (1) Sabino et al.,
2014
1Teleomorph: Neosartorya pseudofischeri.
aspergillosis often relies on suggestive radiological findings
and/or positive fungal biomarkers (galactomannan, beta-1,3-D-
glucan; De Pauw et al., 2008), in the absence of microbiological
documentation and the actual contribution of Aspergillus spp.
other than A. fumigatus in this setting is unknown.
Apart from A. fumigatus, the species of the section Fumigati
that are most frequently recovered in clinical specimens
and associated with invasive fungal diseases are A. lentulus,
A. udagawae, A. viridinutans, A. thermomutatus (Neosartorya
pseudofischeri), A. novofumigatus, and A. hiratsukae (Balajee
et al., 2006, 2009b; Alcazar-Fuoli et al., 2008; Alastruey-Izquierdo
et al., 2013; Escribano et al., 2013). Their limited pathogenic
role compared to A. fumigatus may be explained by a lower
thermotolerance and different profiles of secondary metabolites
with decreased production of mycotoxins, such as gliotoxin
(Frisvad and Larsen, 2015; Tamiya et al., 2015). However, while
resistance to triazoles is rare among A. fumigatus sensu stricto,
these sibling or cryptic species commonly exhibit decreased
susceptibility to azoles and other antifungal agents (Alcazar-
Fuoli et al., 2008; Escribano et al., 2013; Alastruey-Izquierdo
et al., 2014). A recent multicentre prospective survey reported
a rate of azole resistance of 3.2% among A. fumigatus isolates
(van der Linden et al., 2015). Among these resistant strains,
78% were A. fumigatus sensu stricto harboring mutations of the
Cyp51A gene, while the remaining 22% were actually sibling
species (A. lentulus, A. thermomutatus, and A. udagawae).
Microbiologists and clinicians thus must be aware of the existence
of these sibling species that may be the cause of refractory cases
of invasive aspergillosis. The aim of this review is to provide
an overview of the characteristics of the most clinically relevant
Aspergillus spp. of section Fumigati (other than A. fumigatus).
TAXONOMY AND DIVERSITY OF
Aspergillus spp. IN SECTION Fumigati
The genus Aspergillus is divided in subgenera and sections
(Peterson, 2008). A. fumigatus belongs to the section Fumigati,
in which 63 species have now been described, although
some of them are doubtful because of possible synonymy
with other species (Samson et al., 2007; Frisvad and Larsen,
2015). Species delimitation within section Fumigati relies on
a polyphasic approach including phenotypic characteristics,
rate of growth at variable temperatures, extrolite patterns,
and genotyping characterization by random amplification of
polymorphic DNA-polymerase chain reaction (RAPD-PCR)
and multilocus sequence typing (Hong et al., 2005; Samson
et al., 2007). Based on this approach, Yaguchi et al. (2007)
have proposed a subdivision of the section Fumigati into five
clades: (I) A. fumigatus, (II) species including A. lentulus and
A. fumisynnematus, (III) species including A. fumigatiaffinis
and A. novofumigatus, (IV) A. viridinutans, A. udagawae, and
other atypical strains, and (V) species including A. hiratsukae,
A. brevipes, A. duricaulis, and A. unilateralis.
Teleomorphic homothallic species producing ascomata (i.e.,
sexual stage of reproduction) were initially classified under the
genus name Neosartorya. However, many species thought to be
strictly anamorphic further demonstrated the ability to reproduce
sexually with an opposite mating type (e.g., A. fumigatus, and
A. lentulus; O’Gorman et al., 2009; Swilaiman et al., 2013).
From 2012, taxonomists recommend to apply a single-name
nomenclature keeping the name Aspergillus for all species of this
genus (Samson et al., 2014). This system will be used in this
review with reference to the old teleomorphic name in brackets
when applicable.
IDENTIFICATION OF Aspergillus spp. OF
SECTION Fumigati
Morphological examination of macroscopic and microscopic
features remains the standard method for identification of
filamentous fungi. While phenotypic characteristics allow
distinguishing Aspergillus spp. at the section level, accurate
species identification is usually not possible. Compared to
A. fumigatus sensu stricto, other Aspergillus spp. of the section
Fumigati may exhibit distinct morphological features, such as
loss of pigmentation, poor sporulation, presence of ascomata, or
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variable growth at different temperature (Balajee et al., 2005a;
Hong et al., 2005). These distinctive features, summarized in
Table 2, are non-specific and variable, according to the growth
media and conditions. Molecular methods are increasingly
used as an adjunctive diagnostic tool in medical mycology.
However, sequencing methods usually targeting fungal ribosomal
DNA [internal transcribed spacer region (ITS), 18S rDNA,
26S/28S rDNA] are reliable for distinction at the section
level, but not at the species level for Aspergillus spp. (Balajee
et al., 2007). Phylogenetic studies integrate data of partial
DNA sequences of various genes, such as beta-tubulin (benA),
calmodulin, actin and hydrophobin (rodA), to distinguish the
different species within the section Fumigati (Hong et al., 2005;
Samson et al., 2007; Yaguchi et al., 2007). This approach is
fastidious and not convenient for rapid identification in clinical
practice. Currently, experts recommend comparative sequence
analyses of the ribosomal ITS region (ITS1 and ITS2 flanking
regions of the 5.8S rDNA) for intersection identification of
Aspergillus spp. and of the beta-tubulin or calmodulin genes
for intrasection identification at the species level (Balajee et al.,
2007, 2009a; Samson et al., 2014). Multiplex PCR assays
targeting microsatellite markers or specific gene sequences (ITS2
region, benA, rodA) have been developed for rapid detection
and discrimination of Aspergillus species within the section
Fumigati in clinical samples (Serrano et al., 2011; Araujo et al.,
2012; Fernandez-Molina et al., 2014). Other techniques have
also been described, such as PCR-restriction fragment length
polymorphism (PCR-RFLP) of the benA gene (Staab et al., 2009)
and microsphere-based Luminex assay (Etienne et al., 2009).
Matrix-assisted laser desorption ionization – time-of-flight
mass spectrometry (MALDI-TOF MS) also gave promising
results for the distinction between A. fumigatus and A. lentulus
in clinical isolates (Verwer et al., 2014). This approach
demonstrated accuracy for identification of Aspergillus spp.
at the species level (Sanguinetti and Posteraro, 2014). Mass
spectra of A. lentulus and other cryptic Aspergillus spp. have
been included in different commercial or in-house libraries.
However, protein extraction procedures for filamentous fungi
are not standardized and further analyses of mass spectra of
these fungal species, performed under the same experimental
conditions, are warranted in order to obtain a complete reference
database.
CLINICALLY RELEVANT Aspergillus spp.
OF SECTION Fumigati (OTHER THAN
A. fumigatus)
Various cases of fungal infections involving Aspergillus spp. of
section Fumigati other than A. fumigatus have been reported
in the medical literature (Table 3). Clinical presentation is
often similar to that of other invasive aspergillosis and positive
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Phenotypic characteristics are expressed in comparison to A. fumigatus reference wild-type strain (Af293). Max T, maximal temperature at which growth may be observed;
AMB, amphotericin B; TAZ, triazoles (voriconazole, posaconazole, and itraconazole), ECH: echinocandins (caspofungin, micafungin, and anidulafungin); NA, no data
available 1Teleomorph: Neosartorya fischeri/pseudofischeri. 2Aspergillus felis exhibits better growth at 37◦C and is able to growth at 45◦C, while A. viridinutans cannot.
3Aspect on conventional fungal culture media, such as Czapek, Sabouraud dextrose agar or potato dextrose agar. 4Antifungal susceptibility is expressed according to
minimal inhibitory concentrations (MIC) for fungicidal drugs (amphotericin B, triazoles) and minimal effective concentrations (MEC) for fungistatic drugs (echinocandins),
based on data reported from the literature. Grading was assessed as follows: ++ (MIC ≤ 1 µg/ml or MEC ≤ 0.25 µg/ml); + (MIC 1–4 µg/ml or MEC 0.25–2 µg/ml),
− (MIC > 4 µg/ml or MEC > 2 µg/ml). These data are indicative and may display important variations according to each individual isolate. 5Better in vitro activity of
posaconazole compared to voriconazole and itraconazole. 6Better in vitro activity of micafungin and anidulafungin compared to caspofungin.
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fungal biomarkers (galactomannan, beta-1,3-D-glucan) may also
be observed. A. lentulus is the most frequent species recovered
in clinical specimens and mixed infections with concomitant
A. fumigatus are also reported. Invasive fungal infections due to
A. lentulus or other A. fumigatus-related species are associated
with a particularly high mortality rate (about 60%). In addition,
these cryptic species have also been associated with allergic
fungal diseases and chronic colonization in patients with cystic
fibrosis (Shivaprakash et al., 2009; Symoens et al., 2010). Some
microbiological and clinical features of the most clinically
important species will be discussed in this chapter.
Aspergillus lentulus
Aspergillus lentulus was first identified in 2004. While
retrospectively screening for itraconazole resistance in
a collection of 128 A. fumigatus isolates obtained from
hematopoietic stem cell transplant recipients between 1991 and
2000 in Seattle, Balajee et al. (2004) described an A. fumigatus
variant exhibiting poor sporulation and decreased susceptibility
to azoles, amphotericin B and echinocandins. These atypical
isolates were found to be the cause of invasive fungal infections
in 4 (5%) of these patients. On the basis of phylogenetic
analyses, these isolates were assigned to a new species within the
section Fumigati under the name of A. lentulus (Balajee et al.,
2005a). Phenotypic characteristics of A. lentulus compared to
A. fumigatus are poor sporulation, smaller conidial heads and
inability to grow at temperature above 48◦C. Mass spectrometry
methods (MALDI-TOF, SELDI-TOF) showed promising results
for rapid discrimination between A. lentulus and A. fumigatus
(Pinel et al., 2011; Verwer et al., 2014).
Aspergillus lentulus seems to represent only a small proportion
(<3%) of all Aspergillus spp. of the section Fumigati isolated
in clinical specimens (Balajee et al., 2009b; Alastruey-Izquierdo
et al., 2013; Escribano et al., 2013). However, it may account
for a substantial proportion (10–30%) of azole-resistant isolates
that are morphologically classified as A. fumigatus (Mortensen
et al., 2010; Kidd et al., 2015; van der Linden et al., 2015).
Clinical reports of A. lentulus infections mainly consist of
invasive pulmonary aspergillosis in patients with hematologic
malignancies or solid-organ transplant recipients (Balajee et al.,
2004, 2009b; Zbinden et al., 2012; Escribano et al., 2013; Gurcan
et al., 2013; Bastos et al., 2015; Yoshida et al., 2015). Interestingly,
A. lentulus is often found in association with A. fumigatus in
mixed infections with poor outcomes (Alhambra et al., 2008;
TABLE 3 | Case reports of invasive aspergillosis attributed to Aspergillus spp. of section Fumigati other than A. fumigatus.
Species (N cases) Host risk factors Type of infection Outcome Reference





Zbinden et al., 2012; Escribano
et al., 2013; Gurcan et al.,
2013; Bastos et al., 2015;
Yoshida et al., 2015







Vinh et al., 2009b; Posteraro
et al., 2011; Gyotoku et al.,
2012













Gerber et al., 1973; Coriglione
et al., 1990; Summerbell et al.,
1992; Padhye et al., 1994;
Matsumoto et al., 2002; Jarv
et al., 2004; Balajee et al.,
2005b; Ghebremedhin et al.,
2009; Toskova et al., 2013;
Khare et al., 2014






Lonial et al., 1997; Chim et al.,
1998; Gori et al., 1998










Katz et al., 2005; Vinh et al.,
2009a; Coelho et al., 2011;
Shigeyasu et al., 2012






Guarro et al., 2002; Predari
et al., 2007; Koutroutsos et al.,
2010
Mixed2 (8) HM (3)
Solid tumor (3)
COPD (1)
IPA (8) Success (1)
Failure (7)
Alhambra et al., 2008;
Montenegro et al., 2009;
Escribano et al., 2013; Pelaez
et al., 2013
1Teleomorph: N. pseudofischeri. 2Aspergillus lentulus/A. fumigatus (4), A. lentulus/A. udagawae/A. fumigatus (1), A. lentulus/A. novofumigatus/A. fumigatus (1),
A. udagawae/A. fumigatus (1), A. felis/A. novofumigatus/A. calidoustus (1). 3Contiguous extension from lung to adjacent structures frequently reported. SOT, solid-
organ transplantation; COPD, chronic obstructive pulmonary disease; CGD, chronic granulomatous disease; HM, hematologic malignancy; IPA, invasive pulmonary
aspergillosis; NR, not reported.
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Montenegro et al., 2009; Escribano et al., 2013). A. lentulus
was pathogenic in murine models of invasive aspergillosis, but
was associated with a decreased mortality and a delayed course
of infection compared to A. fumigatus (Mellado et al., 2011).
A. lentulus was also pathogenic in larvae of Galleria mellonella
who did not respond to voriconazole therapy (Alcazar-Fuoli et al.,
2015).
Decreased susceptibility to all three antifungal classes (azoles,
polyenes and echinocandins) are reported in most clinical
isolates (Alcazar-Fuoli et al., 2008; Alastruey-Izquierdo et al.,
2013, 2014; Escribano et al., 2013). The level of resistance of
A. lentulus to triazoles is variable, with higher MICs observed
for voriconazole and itraconazole compared to posaconazole.
The new triazole isavuconazole displays good in vitro activity
against A. lentulus (Datta et al., 2013). Intrinsic azole resistance
in A. lentulus is dependant of the Cyp51A gene (AlCyp51A),
which shares 92% homology with its A. fumigatus ortholog
(AfCyp51A). Substitution of AfCyp51A by AlCyp51A induced the
same phenotype of azole resistance in A. fumigatus (Mellado
et al., 2011). Molecular dynamics modeling suggested that some
differences in the BC-loop between AfCyp51A and AlCyp51A
may affect the closed form of the protein upon voriconazole
binding (Alcazar-Fuoli et al., 2011). Among echinocandins,
decreased susceptibility of A. lentulus is mainly observed for
caspofungin (Alcazar-Fuoli et al., 2008; Alastruey-Izquierdo et al.,
2014). However, there was no polymorphisms in the known hot
spot regions of the A. lentulus fks gene (encoding for the β-
1,3-glucan synthase target of echinocandins), which shares 98%
homology with A. fumigatus fks (Staab et al., 2010).
Aspergillus (Neosartorya) udagawae
Aspergillus udagawae was first isolated in 1995 from the soil of a
sugar cane plantation in Brazil (Horie et al., 1995). Morphological
features that may help distinguishing A. udagawae from
A. fumigatus are the decreased spore production and the secretion
of a pink-purple pigment on agar plates. A. udagawae also
exhibits a different range of thermotolerance, being able to grow
at 10◦C, but not at ≥42◦C, with an optimal growth at 30–35◦C
(Sugui et al., 2010). Decreased rates of germination and increased
susceptibility to neutrophils and hydrogen peroxide may explain
the lower virulence of A. udagawae compared to A. fumigatus in
murine models (Sugui et al., 2010; Gyotoku et al., 2012).
Molecular analyses suggest that A. udagawae may account for
a small proportion of the Aspergillus spp. of section Fumigati
isolated from clinical specimens (Balajee et al., 2006; Vinh
et al., 2009b; Escribano et al., 2013). Few clinical cases have
been reported in the literature. A. udagawae may cause a
chronic form of pulmonary aspergillosis with a propensity
for contiguous spread to adjacent structures, which may be
refractory to antifungal therapy (Vinh et al., 2009b). Cases of
endobronchial infection and post-traumatic keratitis have also
been reported in immunocompetent patients (Posteraro et al.,
2011; Gyotoku et al., 2012). A. udagawae isolates usually exhibit
higher MIC (1 to 3 dilutions) to amphotericin B and voriconazole
compared to A. fumigatus sensu stricto (Balajee et al., 2006;
Vinh et al., 2009b). The new triazole isavuconazole demonstrated
increased activity (MIC ranging 0.031–0.25 µg/ml; Datta et al.,
2013).
Aspergillus viridinutans/felis
Aspergillus viridinutans was first isolated from a rabbit dung
in Australia and subsequently documented in some human
clinical isolates (Alcazar-Fuoli et al., 2008; Vinh et al., 2009a;
Coelho et al., 2011; Escribano et al., 2013; Pelaez et al., 2013).
Recently, some specimens previously identified as A. viridinutans
have been reassigned to the novel closely related species
A. pseudoviridinutans, A. felis, A. pseudofelis, and A. parafelis
(Katz et al., 2005; Barrs et al., 2013; Alvarez-Perez et al., 2014;
Sugui et al., 2014). These species sporulate weakly and produce
a typical “nodding” conidial head (Barrs et al., 2013). Contrarily
to A. viridinutans, A. felis is able to grow at 45◦C. A. felis is
a common cause of sino-orbital aspergillosis in cats (Barrs and
Talbot, 2014). Similar to A. udagawae, A. viridinutans, and A. felis
cause human pulmonary aspergillosis characterized by a chronic
evolution and spread across contiguous anatomic planes (Vinh
et al., 2009a; Coelho et al., 2011). A case of fungal keratitis was also
described in human (Shigeyasu et al., 2012). Most clinical isolates
showed high MICs for voriconazole and itraconazole (usually
≥4 µg/ml), but lower values for posaconazole and amphotericin
B (Alcazar-Fuoli et al., 2008; Vinh et al., 2009a; Coelho et al., 2011;




Aspergillus fischeri (teleomorph: N. fischeri) is a ubiquitous fungus
producing thermotolerant ascospores, which is responsible of
food spoilage of fruit juices and other heat-processed fruit
products. A. thermomutatus (teleomorph: N. pseudofischeri) can
only be differentiate from A. fischeri by electron microscopic
analysis of the ascospores (Peterson, 1992). These homothallic
fungi produce whitish fast-growing colonies with few sporulation
at 37◦C and can tolerate higher temperatures (48◦C). Ascomata
of the sexual form are usually abundant, but may be scarce or
appear at later stages, especially at 37◦C.
A. fischeri and A. thermomutatus have been identified as the
cause of human mycoses in only few case reports with a broad
spectrum of disease’s presentation including extrapulmonary
manifestations in most cases, such as endocarditis, osteomyelitis,
peritonitis, gastro-intestinal tract infection, keratitis, and
disseminated infections (Gerber et al., 1973; Coriglione et al.,
1990; Summerbell et al., 1992; Padhye et al., 1994; Lonial et al.,
1997; Chim et al., 1998; Gori et al., 1998; Matsumoto et al., 2002;
Jarv et al., 2004; Balajee et al., 2005b; Ghebremedhin et al., 2009;
Toskova et al., 2013; Khare et al., 2014). Susceptibility testing of
these isolates usually shows higher MICs for triazoles compared
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to A. fumigatus, but similar values for amphotericin B and
echinocandins (Balajee et al., 2005b; Alcazar-Fuoli et al., 2008).
OTHER PATHOGENIC Aspergillus spp. IN
SECTION Fumigati
Aspergillus (Neosartorya) hiratsukae has been identified in some
clinical specimens (Alcazar-Fuoli et al., 2008) and has been
associated with rare and essentially extrapulmonary fungal
diseases, such as cerebral aspergillosis and peritonitis in patients
under peritoneal dialysis (Guarro et al., 2002; Predari et al., 2007;
Koutroutsos et al., 2010). A. novofumigatus, A. fumigatiaffinis,
and A. fumisynnematus have also been isolated in clinical
samples, but their pathogenic role remained unclear (Alcazar-
Fuoli et al., 2008; Escribano et al., 2013; Pelaez et al., 2013).
CONCLUSION
Recent advances in phylogenetic analyses and molecular methods
have revealed the important diversity of Aspergillus species
within the section Fumigati. Some clinical isolates may actually
be misidentified as A. fumigatus by conventional diagnostic
methods, which may result in inappropriate antifungal therapy
because of the decreased susceptibility of these cryptic species
to many antifungal agents. Azole resistance among A. fumigatus
isolates is an emerging problem, which has been highlighted by
multiple recent reports throughout the world, but its prevalence
is still low. Actually, in case of refractory invasive aspergillosis,
clinicians should suspect that a sibling species of A. fumigatus
may be the causal agent. Slow or poor sporulation is usually
the first hint that should alert the microbiologist. Sequencing
of the ITS region, followed by targeted sequencing of the
beta-tubulin or calmodulin genes seems to date the most
appropriate method for reliable species identification. However,
these procedures are not available in most institutions. MALDI-
TOF MS may be a very convenient alternative for the rapid
detection of A. lentulus and other A. fumigatus-related species,
but further investigations for standardized sample treatment
procedures of filamentous fungi and spectra characterization
are required. Antifungal susceptibility testing may be useful
because of the unpredictable susceptibility profile of these species.
However, results should be interpreted with caution because
of the lack of clinical breakpoints and the absence of data
correlating MICs with clinical outcomes. Recommendations for
the antifungal management of such cases cannot be clearly
defined on the basis of limited published data consisting
in case reports of refractory invasive aspergillosis with often
fatal outcomes despite the use of multiple antifungal agents.
Decreased susceptibility to azoles is common and higher MICs
to other antifungal drugs (amphotericin B, caspofungin) may
also be observed, especially for A. lentulus. Among triazoles,
posaconazole displays better in vitro antifungal activity compared
to voriconazole and itraconazole, but is not yet approved
as first-line therapy of invasive aspergillosis. In addition, the
new extended-spectrum isavuconazole, which has recently been
approved for the treatment of invasive aspergillosis (Miceli and
Kauffman, 2015), may become an interesting alternative as both
A. lentulus and A. udagawae displayed low MICs comparable to
that of A. fumigatus (Datta et al., 2013). Combination therapies
may be considered in refractory cases, although data are lacking
to demonstrate a benefit in this setting.
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